Vivani and Novo Nordisk Collaborate on Weight Management Implant
Los angeles: Vivani Medical Inc (Vivani), a biopharmaceutical company focused on developing ultra long-acting drug implants, has entered an agreement with Novo Nordisk to evaluate Vivani’s semaglutide drug implant, NPM-139, aimed at managing chronic w…